You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 19, 2024

J And J Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for J AND J, and what generic and branded alternatives to J AND J drugs are available?

J AND J has thirty-three approved drugs.



Summary for J And J
US Patents:0
Tradenames:26
Ingredients:13
NDAs:33

Drugs and US Patents for J And J

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride SOLUTION;ORAL 019487-001 Mar 1, 1988 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc IMODIUM A-D loperamide hydrochloride TABLET;ORAL 019860-001 Nov 22, 1989 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc PEPCID AC famotidine TABLET, CHEWABLE;ORAL 020801-002 Dec 17, 2007 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-004 Nov 16, 2007 OTC Yes No ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc PEPCID COMPLETE calcium carbonate; famotidine; magnesium hydroxide TABLET, CHEWABLE;ORAL 020958-001 Oct 16, 2000 OTC Yes Yes ⤷  Try a Trial ⤷  Try a Trial
J And J Consumer Inc CHILDREN'S ZYRTEC ALLERGY cetirizine hydrochloride TABLET, CHEWABLE;ORAL 021621-003 Nov 16, 2007 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for J And J

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
J And J Consumer Inc ZYRTEC cetirizine hydrochloride SOLUTION;ORAL 020346-001 Sep 27, 1996 4,525,358*PED ⤷  Try a Trial
J And J Consumer Inc PEPCID AC famotidine TABLET;ORAL 020902-001 Aug 5, 1999 5,667,794*PED ⤷  Try a Trial
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen SUSPENSION/DROPS;ORAL 020603-001 Jun 10, 1996 5,374,659*PED ⤷  Try a Trial
J And J Consumer Inc IMODIUM MULTI-SYMPTOM RELIEF loperamide hydrochloride; simethicone TABLET, CHEWABLE;ORAL 020606-001 Jun 26, 1996 5,716,641 ⤷  Try a Trial
J And J Consumer Inc CHILDREN'S MOTRIN ibuprofen SUSPENSION;ORAL 020516-001 Jun 16, 1995 5,374,659*PED ⤷  Try a Trial
J And J Consumer Inc JUNIOR STRENGTH MOTRIN ibuprofen TABLET, CHEWABLE;ORAL 020601-003 Nov 15, 1996 5,215,755*PED ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for J AND J drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Syrup 5 mg/5 mL ➤ Subscribe 2007-03-19
➤ Subscribe Chewable Tablets 800 mg/ 10 mg/ 165 mg (OTC) ➤ Subscribe 2004-11-01
➤ Subscribe Chewable Tablets 5 mg and 10 mg ➤ Subscribe 2005-03-25
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.